Aquestive Therapeutics (AQST) P/S (2018 - 2026)
Aquestive Therapeutics (AQST) P/S from Jul 25, 2018 to Jul 20, 2026. The TTM Aquestive Therapeutics (AQST) P/S is 9.75. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Aquestive Therapeutics (AQST)
| Year | P/S | Change |
|---|---|---|
| 2026 | 9.75 | -44.90% |
| 2025 | 17.70 | +213.01% |
| 2024 | 5.65 | +101.51% |
| 2023 | 2.81 | +177.69% |
| 2022 | 1.01 | -67.97% |
| 2021 | 3.15 | -21.78% |
| 2020 | 4.03 | +8.62% |
| 2019 | 3.71 | +59.23% |
| 2018 | 2.33 | N/A |
Comparison Aquestive Therapeutics (AQST) P/S with competitors
Aquestive Therapeutics (AQST) P/S is 9.75.